NorthStar Asset Management (New Jersey)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,719
Closed -$237K – 104
2025
Q4
$237K Buy
+1,719
New +$225K 0.11% 95

Other funds holding NVS

NorthStar Asset Management (New Jersey)'s NVS Position: Q1 2026 in Review

NorthStar Asset Management (New Jersey) sold out of Novartis (NVS) in Q1 2026, closing a stake of 1,719 shares — an estimated $237K sold.

NorthStar Asset Management (New Jersey) first reported a position in NVS in Q4 2025 and held it in 1 quarter. The position peaked at $237K in Q4 2025. 1,605 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • NorthStar Asset Management (New Jersey) reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • NorthStar Asset Management (New Jersey) sold 1,719 Novartis shares in Q1 2026, an estimated $237K.
  • NorthStar Asset Management (New Jersey) first reported a position in Novartis in Q4 2025 and held it in 1 quarter.
  • NorthStar Asset Management (New Jersey)'s Novartis position peaked at $237K in Q4 2025.
  • 1,605 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on NorthStar Asset Management (New Jersey)'s 13F filing for Q1 2026, filed 8 May 2026.